Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2000
03/30/2000WO2000016708A1 Methods and systems for treating breast tissue
03/30/2000WO2000016631A1 Murf2
03/30/2000WO2000016609A1 Novel method of regulating seed development in plants and genetic sequences therefor
03/30/2000WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
03/30/2000WO2000003026A3 Transcription coactivators
03/30/2000WO2000002913B1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
03/30/2000WO2000000614A9 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI)
03/30/2000WO2000000609A3 Molecules associated with apoptosis
03/30/2000WO2000000483A9 Tubulin binding compounds (cobra)
03/30/2000WO2000000214A3 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
03/30/2000WO1999067426A8 Absorptive hypercalciuria locus on human chromosome 1
03/30/2000WO1999067393A3 Aav scleroprotein, production and use thereof
03/30/2000WO1999066959A9 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival
03/30/2000WO1999064593A3 Cell cycle regulation proteins
03/30/2000WO1999061608A3 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
03/30/2000WO1999061601A9 Aav5 vector and uses thereof
03/30/2000WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof
03/30/2000WO1999058687A3 Bacillus thuringiensis toxins and genes for controlling coleopteran pests
03/30/2000WO1999057565A3 Methods for diagnosing and evaluating cancer
03/30/2000WO1999057281A3 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same
03/30/2000WO1999054470A3 Bacterial ygjd polypeptide family
03/30/2000WO1999053091A3 Dna coding for gdnf, parts of said dna and gdnf variants
03/30/2000WO1999053055A3 Therapeutic agent for ngf
03/30/2000WO1999051744A3 A interleukin-1 receptor antagonist and uses thereof
03/30/2000WO1999049892A3 Use of active p40 conjugates for nasal delivery
03/30/2000WO1999042477A3 Transporter protein for saccharide-coupled medicaments
03/30/2000WO1999041974A9 Methods for improving seeds
03/30/2000WO1999038980A3 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000DE19856261C1 Detection of gamma-secretase by detection of A-beta peptide useful for determining gamma-secretase activity and for identifying inhibitors
03/30/2000CA2689373A1 G protein-coupled receptor antagonists
03/30/2000CA2345088A1 Gpr10 as a target for identifying weight modulating compounds
03/30/2000CA2344699A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344370A1 Chemokine receptor antagonist and cyclosporin in combined therapy
03/30/2000CA2344277A1 Cystine knot growth factor mutants
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343978A1 Novel method of regulating seed development in plants and genetic sequences therefor
03/30/2000CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000CA2343879A1 Diagnostic assays for detection of cryptosporidium parvum
03/30/2000CA2343718A1 Human chaperone proteins
03/30/2000CA2343697A1 Cyclin d polynucleotides, polypeptides and uses thereof
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343324A1 Polynucleotide constructs and uses thereof
03/30/2000CA2343320A1 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
03/30/2000CA2343090A1 Retroviral particles protected against complement mediated destruction
03/30/2000CA2343078A1 Method for the diagnosis of cell proliferative disease
03/30/2000CA2343004A1 Alzheimer's disease secretase
03/30/2000CA2342957A1 Regulatory protein from human keratinocytes
03/30/2000CA2342773A1 Interferon-epsilon
03/30/2000CA2339866A1 Recombinant celo virus and celo virus dna
03/30/2000CA2339595A1 Binary viral expression system in plants
03/30/2000CA2283540A1 Anti-fas antibodies
03/29/2000EP0989186A1 Novel stat function-regulatory protein
03/29/2000EP0989136A1 Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants
03/29/2000EP0988399A1 Dna sequences rich in triplet repeat useful in the diagnosis of trinucleotide repeat disorders
03/29/2000EP0988395A2 Assay methods and compositions useful for measuring receptor ligand binding
03/29/2000EP0988391A2 Recombinant adenoviral vectors comprising a splicing sequence
03/29/2000EP0988390A1 Alternatively targeted adenovirus
03/29/2000EP0988388A2 Ghrh expression system and methods of use
03/29/2000EP0988385A2 Tace-like and matrilysin-like polypeptides
03/29/2000EP0988381A1 T-cell receptor beta-like protein
03/29/2000EP0988380A1 Translational regulator initiation factor 4e-binding protein
03/29/2000EP0988379A1 Ldl-receptor
03/29/2000EP0988377A1 Zinc finger protein derivatives and methods therefor
03/29/2000EP0988376A2 Noey2 gene compositions and methods of use
03/29/2000EP0988371A1 Human tumor necrosis factor receptor tr9
03/29/2000EP0988321A2 B7-binding molecules for treating immune diseases
03/29/2000EP0988320A1 Cyclic crf agonists
03/29/2000EP0988319A1 Human l105 proteins and polynucleotides encoding same
03/29/2000EP0988318A2 Human extracellular matrix proteins
03/29/2000EP0988317A2 Aib1, a steroid receptor co-activator
03/29/2000EP0988316A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
03/29/2000EP0988314A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
03/29/2000EP0988051A1 Lyme combination compositions and uses
03/29/2000EP0988049A2 Pharmaceutical composition for treating hepatitis b virus (hbv) infection
03/29/2000EP0988048A1 Ligand/lytic peptide compositions and methods of use
03/29/2000EP0988047A1 Soluble ctla4 mutant molecules and uses thereof
03/29/2000EP0988045A1 Peptide nucleic acid monomers and oligomers
03/29/2000EP0987943A1 A novel method of detecting and treating cancer
03/29/2000EP0777689B1 Use of cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
03/29/2000EP0697891B1 Polyoxime compounds and their preparation
03/29/2000CN1249001A Acarbose (ACB) cluster from actinoplanes sp. SE 50/110
03/29/2000CN1248625A Novel human gene coding sequence, its coded polypeptide and preparation process thereof
03/29/2000CN1248624A Novel human capside protein subunit coding sequence, its coded polypeptide and preparation process
03/28/2000US6043415 Nucleotide sequence for insecticidal protein used to control insects of the spodoptera and mamestra species; production of transformed cells and transgenic plants
03/28/2000US6043410 Linked to heterologous dna sequence encoding polypeptide of interest; for high levels of transcription in ripening fruit tissue and in developing seed tissues of transgenic plants
03/28/2000US6043357 Stability, efficiency; treating human immuno deficiency viurs
03/28/2000US6043351 Epstein Barr virus induced genes
03/28/2000US6043348 Antibody recognizing a small subset of human hematopoietic cells
03/28/2000US6043347 Compositions and methods for treating viral infections
03/28/2000US6043346 Antibody that binds to a tub polypeptide
03/28/2000US6043344 Human CTLA-8 and uses of CTLA-8-related proteins
03/28/2000US6043343 Amino acid sequence; for diagnosis and prevention of cancer and tumors; anticarcinogenic/antitumor agents; for screening compounds which bind to polypeptide
03/28/2000US6043342 Human protein whose presence indicates ongoing neoplastic development within cells and tissues of epithelial cell origin and thus is a reliable and reproducible biochemical marker
03/28/2000US6043340 Synthetic peptide having amino acid sequence encoded by genetic suppressor element isolated from kinesin gene; for investigating drug resistance
03/28/2000US6043339 Heterologous complex of polypeptides or nucleic acids which are linked to an importation competent signal peptide and to a nuclear localization peptide; for peptide and gene therapy and antisense agents
03/28/2000US6043222 Two new human DnaJ-like proteins
03/28/2000US6043221 Method for preventing and treating hearing loss using a neuturin protein product
1 ... 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 ... 2916